Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Mazzarol

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvementMarco Colleoni, Nicole Rotmensz, Giulia Peruzzotti, et al.
World Journal of Surgical Oncology|September 12, 2012
Recurrence and prognostic factors in patients with aggressive fibromatosis. The role of radical surgery and its limitationsEmilio Bertani, Alessandro Testori, Antonio Chiappa, et al.
Oncology|September 19, 2023
Clinical Implication of CDH1 Mutations in Genetic Testing for Diffuse Gastric Cancer PatientsGiovanni Corso, Cristina Maria Trovato, Salvatore Petitto, et al.
Archives of Surgery (Chicago, Ill. : 1960)|March 4, 2003
Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breastMattia Intra, Paolo Veronesi, Giovanni Mazzarol, et al.
Annals of Surgical Oncology|February 24, 2016
Erratum to: Oncoplastic Breast-Conserving Surgery for Tumors Larger than 2 Centimeters: Is it Oncologically Safe? A Matched-Cohort AnalysisFrancesca De Lorenzi, Pietro Loschi, Vincenzo Bagnardi, et al.
Annals of Surgical Oncology|February 5, 2016
Oncoplastic Breast-Conserving Surgery for Tumors Larger than 2 Centimeters: Is it Oncologically Safe? A Matched-Cohort AnalysisFrancesca De Lorenzi, Pietro Loschi, Vincenzo Bagnardi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 16, 2018
Oncoplastic breast surgery for the management of ductal carcinoma in situ (DCIS): is it oncologically safe? A retrospective cohort analysisFrancesca De Lorenzi, Julien Di Bella, Patrick Maisonneuve, et al.
Annals of Surgery|December 25, 2007
Comparative evaluation of an extensive histopathologic examination and a real-time reverse-transcription-polymerase chain reaction assay for mammaglobin and cytokeratin 19 on axillary sentinel lymph nodes of breast carcinoma patientsGiuseppe Viale, Patrizia Dell'Orto, Maria O Biasi, et al.
Clinical Genitourinary Cancer|February 21, 2017
Reliability of Frozen Section Examination in a Large Cohort of Testicular Masses: What Did We Learn?Deliu Victor Matei, Mihai Dorin Vartolomei, Giuseppe Renne, et al.
Annals of Surgical Oncology|October 6, 2021
Oncoplastic Breast-Conserving Surgery for Synchronous Multicentric and Multifocal Tumors: Is It Oncologically Safe? A Retrospective Matched-Cohort AnalysisFrancesca De Lorenzi, Francesco Borelli, Eleonora Pagan, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvementMarco Colleoni, Nicole Rotmensz, Giulia Peruzzotti, et al.
World Journal of Surgical Oncology|September 12, 2012
Recurrence and prognostic factors in patients with aggressive fibromatosis. The role of radical surgery and its limitationsEmilio Bertani, Alessandro Testori, Antonio Chiappa, et al.
Oncology|September 19, 2023
Clinical Implication of CDH1 Mutations in Genetic Testing for Diffuse Gastric Cancer PatientsGiovanni Corso, Cristina Maria Trovato, Salvatore Petitto, et al.
Archives of Surgery (Chicago, Ill. : 1960)|March 4, 2003
Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breastMattia Intra, Paolo Veronesi, Giovanni Mazzarol, et al.
Annals of Surgical Oncology|February 24, 2016
Erratum to: Oncoplastic Breast-Conserving Surgery for Tumors Larger than 2 Centimeters: Is it Oncologically Safe? A Matched-Cohort AnalysisFrancesca De Lorenzi, Pietro Loschi, Vincenzo Bagnardi, et al.
Annals of Surgical Oncology|February 5, 2016
Oncoplastic Breast-Conserving Surgery for Tumors Larger than 2 Centimeters: Is it Oncologically Safe? A Matched-Cohort AnalysisFrancesca De Lorenzi, Pietro Loschi, Vincenzo Bagnardi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 16, 2018
Oncoplastic breast surgery for the management of ductal carcinoma in situ (DCIS): is it oncologically safe? A retrospective cohort analysisFrancesca De Lorenzi, Julien Di Bella, Patrick Maisonneuve, et al.
Annals of Surgery|December 25, 2007
Comparative evaluation of an extensive histopathologic examination and a real-time reverse-transcription-polymerase chain reaction assay for mammaglobin and cytokeratin 19 on axillary sentinel lymph nodes of breast carcinoma patientsGiuseppe Viale, Patrizia Dell'Orto, Maria O Biasi, et al.
Clinical Genitourinary Cancer|February 21, 2017
Reliability of Frozen Section Examination in a Large Cohort of Testicular Masses: What Did We Learn?Deliu Victor Matei, Mihai Dorin Vartolomei, Giuseppe Renne, et al.
Annals of Surgical Oncology|October 6, 2021
Oncoplastic Breast-Conserving Surgery for Synchronous Multicentric and Multifocal Tumors: Is It Oncologically Safe? A Retrospective Matched-Cohort AnalysisFrancesca De Lorenzi, Francesco Borelli, Eleonora Pagan, et al.
Pageof 9